MOBILion Systems To Highlight Customer Use Cases From Its MOBIE® Platform and Unveil Plans for Their Next Generation Proteomics Platform at ASMS 2025

MOBILion Systems, Inc., will attend and exhibit at the 73rd Annual American Society for Mass Spectrometry (ASMS) Conference in Baltimore, MD from June 1–5. The company will highlight the transformative impact its MOBIE^® High-Resolution Ion Mobility product is having across a wide range of applications and showcase early performance of its next-generation proteomics system, BILLIE™.

More than 50 abstracts including oral and poster presentations will demonstrate how independent researchers across pharmaceutical development, chiral molecule analysis, lipidomics and PFAS research are driving innovation with the MOBIE system. These real-world applications reflect growing market adoption and the expanding impact of MOBILion’s existing MOBIE product across critical and emerging workflows. Alongside its commercial platform, MOBILion will present the latest data and collaborator results powered by its most recent advancement: Parallel Accumulation Mobility Aligned Fragmentation (PAMAF). This novel mode of operation is the foundation for the forthcoming BILLIE platform, enabling increased speed, sensitivity, and selectivity for LC-HRMS-based proteomics.

“ASMS is the ideal venue to highlight the exciting breakthroughs our users are achieving with the MOBIE system, and to share where we are heading with BILLIE,” said Melissa Sherman, Ph.D., CEO of MOBILion Systems. “Our team has been on a journey to improve separation science, holistically. There is nothing more rewarding than seeing our users show to industry peers the characterization boundaries being broken with the MOBIE product. This year is particularly exciting for the MOBILion team because we are also providing a first look of our next product in development. The performance improvements BILLIE will offer through PAMAF represent a true step-change in mass spectrometry workflows allowing researchers to push the boundaries of what’s possible in proteomics and beyond.”

PAMAF is designed to address the long-standing limitations of traditional tandem quadrupole mass spectrometry by replacing the slow and lossy quadrupole isolation step with high-resolution ion mobility separation. This allows BILLIE to deliver MS/MS fragmentation at over 500 Hz and utilize nearly 100% of available ions, resulting in faster data acquisition, greater signal sensitivity, and improved quantitative accuracy in even the most challenging biological samples.

Daniel DeBord, Ph.D., Chief Technology Officer at MOBILion, added, “For over two decades, scientists have worked to overcome the speed and sensitivity limitations of traditional MS workflows. PAMAF enables fragmentation data with dramatically higher signal-to-noise at speeds up to five times faster than conventional systems. We’re excited to showcase this next frontier in proteomics at ASMS.”